You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR SECRETIN SYNTHETIC HUMAN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for secretin synthetic human

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00036231 ↗	Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction	Terminated	Repligen Corporation	Phase 3	2002-04-01	The purpose of the study is to determine the effect of multiple doses of secretin on autism.
NCT00036244 ↗	Synthetic Human Secretin in Children With Autism	Completed	Repligen Corporation	Phase 3	2002-04-01	The purpose of the study is to determine whether multiple doses of secretin are safe and effective in the treatment of children with autism.
NCT00065962 ↗	Secretin for the Treatment of Autism	Completed	National Institute on Deafness and Other Communication Disorders (NIDCD)	Phase 3	1999-06-01	Many drugs used to treat autism target specific symptoms, such as hyperactivity and aggressiveness. Few drugs target the core autistic symptoms of impaired social interaction and communication. This study will evaluate two forms of the drug secretin for the treatment of core autistic symptoms.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for secretin synthetic human

Condition Name

Chart
Table

Condition Name for secretin synthetic human
Intervention	Trials
Autism	3
Chronic Pancreatitis	2
Intraductal Papillary Mucinous Neoplasms	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for secretin synthetic human
Intervention	Trials
Pancreatitis	4
Autistic Disorder	3
Pancreatitis, Chronic	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for secretin synthetic human

Trials by Country

Map
Table

Trials by Country for secretin synthetic human
Location	Trials
United States	21
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for secretin synthetic human
Location	Trials
Massachusetts	4
Indiana	2
Colorado	2
Washington	2
Michigan	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for secretin synthetic human

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for secretin synthetic human
Clinical Trial Phase	Trials
Phase 3	5
Phase 2	2
Phase 1	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for secretin synthetic human
Clinical Trial Phase	Trials
Completed	5
Terminated	4
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for secretin synthetic human

Sponsor Name

Chart
Table

Sponsor Name for secretin synthetic human
Sponsor	Trials
Repligen Corporation	4
Massachusetts General Hospital	3
ChiRhoClin, Inc.	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for secretin synthetic human
Sponsor	Trials
Other	6
Industry	6
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.